{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:50:50Z","timestamp":1785167450086,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Catholic University of Health and Allied Sciences"},{"name":"Weill Cornell Global Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/mmy\/myy107","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T11:59:48Z","timestamp":1538740788000},"page":"566-572","source":"Crossref","is-referenced-by-count":11,"title":["Virulence and susceptibility patterns of clinical Candida spp. isolates from a tertiary hospital, Tanzania"],"prefix":"10.1093","volume":"57","author":[{"given":"Martha F","family":"Mushi","sequence":"first","affiliation":[{"name":"Department of Microbiology and immunology, Weill Bugando School of Medicine, Catholic University of Heath and Allied Sciences Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bader","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, University Medical Center Gottingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bii","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute, Center for Microbiology Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Gro\u00df","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, University Medical Center Gottingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Mshana","sequence":"additional","affiliation":[{"name":"Department of Microbiology and immunology, Weill Bugando School of Medicine, Catholic University of Heath and Allied Sciences Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"2019061820001695900_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijid.2016.07.001","article-title":"High oral carriage of non-albicans Candida spp. among HIV-infected individuals","volume":"49","author":"Mushi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"2019061820001695900_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1099\/jmm.0.069773-0","article-title":"Oral Candida carriage and immune status in Thai human immunodeficiency virus-infected individuals","volume":"63","author":"Thanyasrisung","year":"2014","journal-title":"J Med Microbiol"},{"key":"2019061820001695900_bib3","doi-asserted-by":"crossref","first-page":"1317579","DOI":"10.1080\/20002297.2017.1317579","article-title":"Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa","volume":"9","author":"Mushi","year":"2017","journal-title":"J Oral Microbiol"},{"key":"2019061820001695900_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida spp. infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"2019061820001695900_bib5","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1128\/JCM.00403-07","article-title":"Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2019061820001695900_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2019061820001695900_bib8","first-page":"122","article-title":"Candidaemia in patients of a tertiary health care hospital from North India","volume":"117","author":"Verma","year":"2003","journal-title":"Indian J Med Res"},{"key":"2019061820001695900_bib9","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib10","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/JCM.00654-09","article-title":"Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2162 clinical isolates of Candida spp. and other yeasts","volume":"47","author":"Espinel-Ingroff","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib11","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1099\/00221287-147-8-1997","article-title":"Candida albicans proteinases: resolving the mystery of a gene family","volume":"147","author":"Hube","year":"2001","journal-title":"Microbiology"},{"key":"2019061820001695900_bib12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.archoralbio.2014.05.017","article-title":"Aliphatic fatty acids and esters: Inhibition of growth and exoenzyme production of Candida, and their cytotoxicity in vitro: anti-Candida effect and cytotoxicity of fatty acids and esters","volume":"59","author":"Souza","year":"2014","journal-title":"Arch Oral Biol"},{"key":"2019061820001695900_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00284-013-0459-6","article-title":"Hemolytic factor production by clinical isolates of Candida spp","volume":"68","author":"Favero","year":"2014","journal-title":"Curr Microbiol"},{"key":"2019061820001695900_bib14","first-page":"DC15","article-title":"Comparison between virulence factors of Candida albicans and non-albicans species of Candida isolated from genitourinary tract","volume":"8","author":"Udayalaxmi","year":"2014","journal-title":"JCDR"},{"key":"2019061820001695900_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature17625","article-title":"Candidalysin is a fungal peptide toxin critical for mucosal infection","volume":"532","author":"Moyes","year":"2016","journal-title":"Nature"},{"key":"2019061820001695900_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0255-0857.148392","article-title":"Detection of phospholipase activity of Candida albicans and non-albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area","volume":"33","author":"Fule","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"2019061820001695900_bib17","first-page":"654","article-title":"Candida albicans isolates from a Malaysian hospital exhibit more potent phospholipase and haemolysin activities than non-albicans Candida isolates","volume":"30","author":"Chin","year":"2013","journal-title":"Trop Biomed"},{"key":"2019061820001695900_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/00365540902777105","article-title":"Recent experience with fungaemia: change in species distribution and azole resistance","volume":"41","author":"Chakrabarti","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"2019061820001695900_bib20","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous fungi; Approved Standard\u2014Second Edition\u2014Document M38-A2","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"2019061820001695900_bib21","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2019061820001695900_bib22","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AAC.49.9.3616-3623.2005","article-title":"Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome","volume":"49","author":"Kartsonis","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"2019061820001695900_bib23","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/JCM.02128-14","article-title":"Yeast on-target lysis (YOTL), a procedure for making auxiliary mass spectrum data sets for clinical routine identification of yeasts","volume":"52","author":"Bernhard","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00362178485380331","article-title":"Factors affecting the phospholipase activity of Candida species in vitro","volume":"22","author":"Samaranayake","year":"1984","journal-title":"Sabouraudia"},{"key":"2019061820001695900_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00362178285380031","article-title":"Plate method for detection of phospholipase activity in Candida albicans","volume":"20","author":"Price","year":"1982","journal-title":"Sabouraudia"},{"key":"2019061820001695900_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/IAI.56.3.626-631.1988","article-title":"Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa","volume":"56","author":"Borg","year":"1988","journal-title":"Infect Immun"},{"key":"2019061820001695900_bib27","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/JCM.39.8.2971-2974.2001","article-title":"Candida species exhibit differential in vitro hemolytic activities","volume":"39","author":"Luo","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib28","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1128\/JCM.41.12.5792-5793.2003","article-title":"Expression of plasma coagulase among pathogenic Candida species","volume":"41","author":"Rodrigues","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib31","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/AAC.46.11.3518-3521.2002","article-title":"In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2019061820001695900_bib32","volume-title":"Candidiasis, Fungemia","author":"Carpio"},{"key":"2019061820001695900_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11046-007-9053-4","article-title":"Acid proteinase, phospholipase, and biofilm production of Candida spp. isolated from blood cultures","volume":"164","author":"Gokce","year":"2007","journal-title":"Mycopathologia"},{"key":"2019061820001695900_bib34","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jmm.0.47303-0","article-title":"Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus","volume":"56","author":"Tsang","year":"2007","journal-title":"J Med Microbiol"},{"key":"2019061820001695900_bib35","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1111\/j.1439-0507.2011.02125.x","article-title":"Virulence attributes and genetic variability of oral Candida albicans and Candida tropicalis isolates","volume":"55","author":"da Costa","year":"2012","journal-title":"Mycoses"},{"key":"2019061820001695900_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/02681219280000821","article-title":"Candida acid proteinases","volume":"30","author":"R\u00fcchel","year":"1992","journal-title":"J Med Vet Mycol"},{"key":"2019061820001695900_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/313580","article-title":"Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo","volume":"30","author":"Sobel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2019061820001695900_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jac\/dkm423","article-title":"Potential confusion regarding the term \u2018resistance\u2019in epidemiological surveys","volume":"61","author":"Simjee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2019061820001695900_bib39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JCM.02161-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-8-135","article-title":"Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis","volume":"8","author":"Hamza","year":"2008","journal-title":"BMC Microbiol"},{"key":"2019061820001695900_bib41","first-page":"142","article-title":"Fluconazole resistant opportunistic oro-pharyngeal candida and non-candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria","volume":"8","author":"Enwuru","year":"2008","journal-title":"Afr Health Sci"},{"key":"2019061820001695900_bib42","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1128\/JCM.01230-13","article-title":"Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida spp. as determined by the colorimetric Sensititre YeastOne method","volume":"51","author":"Cant\u00f3n","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2019061820001695900_bib43","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"Presence of an FKS mutation rather than minimum inhibitory concentration is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob","volume":"56","author":"Shields","year":"2012","journal-title":"Agents Chemother"},{"key":"2019061820001695900_bib44","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2019061820001695900_bib45","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal candidiasis is a hidden reservoir of echinocandin resistance","volume":"58","author":"Shields","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2019061820001695900_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF00158576","article-title":"Drug resistance in human pathogenic fungi","volume":"8","author":"Iwata","year":"1992","journal-title":"Eur J Epidemiol"},{"key":"2019061820001695900_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1439-0507.1996.tb00152.x","article-title":"Increased prevalence of oral Candida albicans serotype B in homosexual men: a comparative and longitudinal study in HIV-infected and HIV-negative patients","volume":"39","author":"Torssander","year":"1996","journal-title":"Mycoses"},{"key":"2019061820001695900_bib48","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/57\/5\/566\/28683850\/myy107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T03:13:17Z","timestamp":1605150797000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/57\/5\/566\/5149883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,10,31]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myy107","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,10,31]]}}}